軟性內視鏡市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024年，全球軟性內視鏡市場規模達81億美元，預計到2034年將以7.3%的複合年成長率成長，達到162億美元。這一成長趨勢的推動因素包括慢性病病例的增加、微創手術的日益普及以及人們對早期診斷護理的認知的提高。隨著越來越多的患者尋求風險更低、恢復更快、成本更低的手術，軟性內視鏡在醫療保健系統中的應用日益廣泛。可視化技術的持續創新、精密工具的增強以及患者舒適度的提升也提升了這些設備的吸引力。此外，門診和流動護理環境的日益普及也創造了新的需求，而軟性內視鏡為各個臨床學科提供了可擴展且經濟高效的診斷和治療解決方案。

軟性內視鏡具有柔韌的插入管，使醫生能夠在診斷和外科手術過程中輕鬆導航複雜的解剖結構，而無需進行大切口。它們在支持微創醫療方面的作用正在迅速擴大。由於其恢復速度更快、創傷更小、整體成本更低等優勢，患者和醫生對這些設備的偏好日益成長。這些設備已成為現代治療工作流程中的基礎，能夠提供精準高效的護理，尤其是在複雜病例中。

2024年，視訊內視鏡佔據全球市場佔有率的64.6%。這一優勢歸功於其卓越的影像清晰度、即時視覺化以及在廣泛臨床專科領域的適應性。視訊內視鏡採用微型攝影機和先進的光學元件，可將高清影像傳輸至外部顯示器，從而顯著提高診斷準確性並支援複雜的干涉措施。其應用領域涵蓋胃腸病學、肺病學、婦科和泌尿科。這些特性鞏固了其作為微創醫療領域精準醫療重要工具的地位。

2024年，胃腸內視鏡檢查市場佔有40.6%的佔有率。消化道疾病發生率的上升以及公眾對常規篩檢日益成長的興趣是推動該領域發展的關鍵因素。胃腸內視鏡檢查因其能夠減少住院時間並提高患者舒適度，正持續成為一種首選的診斷方法。該領域的成長也反映了內視鏡技術的持續進步，這些技術使檢查更加高效、安全，並推動了全球醫療保健機構對其的廣泛採用。

2024年，美國軟性內視鏡市場規模達32億美元。該地區受益於強大的醫療基礎設施、先進醫療設備的廣泛應用以及日益成長的老年人口，老年人口的醫療保健需求也日益成長。由於對早期診斷和頻繁篩檢的高需求，美國仍然是該地區成長的主要貢獻者。現代內視鏡系統在醫院和門診中心的強勁滲透，將繼續推動這個成熟且持續成長的市場擴張。

全球軟性內視鏡市場的主要參與者包括 CooperSurgical、XION、PENTAX Medical、STORZ、RICHARD WOLF、Machida、Boston Scientific、FUJIFILM、BD、ENDOMED SYSTEMS、Laborie 和 OLYMPUS。在軟性內視鏡市場營運的公司正專注於透過技術先進且方便用戶使用的系統擴展其產品供應。研發方面的策略性投資旨在開發具有增強機動性和 AI 輔助視覺化的超薄、高清內視鏡。製造商還利用與醫院和專科診所的合作夥伴關係，以促進產品在各種護理環境中的獲取和部署。此外，他們正在努力透過監管部門的批准和在新興經濟體建立本地製造中心來擴大地理覆蓋範圍。市場領導者正在投資售後支援、維護服務和醫生培訓計劃，以增強品牌忠誠度。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 慢性病盛行率不斷上升
    • 技術進步
    • 微創療法日益普及
    • 健康意識不斷提高，早期診斷需求不斷增加
  • 產業陷阱與挑戰
    • 嚴格的監管流程
  • 市場機會
    • 人工智慧與機器人系統的整合
    • 醫療保健投資不斷增加
• 成長潛力分析
• 監管格局
  • 北美洲
  • 歐洲
• 技術進步
  • 當前的技術趨勢
  • 新興技術
• 2024年定價分析
• 報銷場景
• 向一次性/一次性軟性內視鏡過渡
• 管道分析
• 啟動場景
• 波特的分析
• PESTEL分析
• 未來市場趨勢
• 差距分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係和合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：按產品，2021 - 2034 年

• 主要趨勢
• 電子內視鏡
• 纖維鏡

第6章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 胃腸內視鏡檢查
• 肺內視鏡檢查
• 耳鼻喉內視鏡檢查
• 泌尿科
• 其他應用

第7章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院和診所
• 門診手術中心
• 其他最終用戶

第8章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• BD
• Boston Scientific
• CooperSurgical
• ENDOMED SYSTEMS
• FUJIFILM
• Laborie
• Machida
• OLYMPUS
• PENTAX Medical
• RICHARD WOLF
• STORZ
• XION

The Global Flexible Endoscopes Market was valued at USD 8.1 billion in 2024 and is estimated to grow at a CAGR of 7.3% to reach USD 16.2 billion by 2034. This growth trajectory is fueled by the rising number of chronic disease cases, the increasing shift toward minimally invasive procedures, and heightened awareness of early-stage diagnostic care. As more patients seek procedures with lower risks, faster recovery, and lower costs, flexible endoscopy continues to gain ground across healthcare systems. Continuous innovation in visualization technologies, enhanced precision tools, and improved patient comfort is also elevating the appeal of these devices. Additionally, the rising popularity of outpatient and ambulatory care settings is creating new demand, with flexible endoscopes offering scalable, cost-effective diagnostic and therapeutic solutions across clinical disciplines.

The flexible endoscopes feature a pliable insertion tube that allows physicians to navigate complex anatomical structures during diagnostic and surgical procedures without large incisions. Their role in supporting less-invasive healthcare is expanding rapidly. The preference for these devices is rising among both patients and physicians due to advantages such as faster recovery, reduced trauma, and lower overall costs. These devices have become fundamental in modern treatment workflows by enabling precise and efficient care delivery, particularly in complex cases.

In 2024, the videoendoscope segment accounted for 64.6% of the global market. This dominance is attributed to their superior image clarity, real-time visualization, and adaptability across a wide range of clinical specialties. Videoendoscopes use miniaturized cameras and advanced optics that deliver high-definition visuals to external displays, greatly enhancing diagnostic accuracy and supporting complex interventions. Their use spans across gastroenterology, pulmonology, gynecology, and urology. These features have cemented their place as essential tools for precision medicine in minimally invasive care settings.

The gastrointestinal (GI) endoscopy segment held a 40.6% share in 2024. Increasing rates of digestive tract disorders and growing public interest in routine screening are key factors boosting this segment. GI endoscopy continues to grow as a preferred diagnostic method due to its ability to reduce hospital stays and improve patient comfort. This segment's growth also reflects ongoing advancements in endoscopic technology that make procedures more efficient and safer, driving increased adoption across healthcare providers globally.

U.S. Flexible Endoscopes Market was valued at USD 3.2 billion in 2024. The region benefits from a robust healthcare infrastructure, widespread use of advanced medical equipment, and a growing senior population with increasing healthcare needs. The U.S. remains a primary contributor to growth within the region, supported by high demand for early diagnostics and frequent screenings. Strong penetration of modern endoscopy systems across hospitals and outpatient centers continues to fuel expansion in this mature yet growing market.

Key players in the Global Flexible Endoscopes Market include CooperSurgical, XION, PENTAX Medical, STORZ, RICHARD WOLF, Machida, Boston Scientific, FUJIFILM, BD, ENDOMED SYSTEMS, Laborie, and OLYMPUS. Companies operating in the flexible endoscopes market are focusing on expanding their product offerings with technologically advanced and user-friendly systems. The strategic investments in R&D aim to develop ultra-thin, high-definition scopes with enhanced maneuverability and AI-assisted visualization. Manufacturers are also leveraging partnerships with hospitals and specialty clinics to boost product access and deployment across varied care settings. Additionally, efforts are underway to expand their geographic reach through regulatory approvals and local manufacturing hubs in emerging economies. Market leaders are investing in after-sales support, maintenance services, and physician training programs to strengthen brand loyalty.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of chronic conditions
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Increasing popularity of minimally invasive therapies
    • 3.2.1.4 Rising health awareness and demand for early-stage diagnosis
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory process
  • 3.2.3 Market opportunities
    • 3.2.3.1 Integration of AI and robotic systems
    • 3.2.3.2 Rising healthcare investments
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
• 3.5 Technological advancements
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Pricing analysis, 2024
  • 3.6.1 North America
  • 3.6.2 Europe
  • 3.6.3 Asia Pacific
  • 3.6.4 Latin America
  • 3.6.5 MEA
• 3.7 Reimbursement scenario
• 3.8 Transition toward single-use/disposable flexible endoscopes
• 3.9 Pipeline analysis
• 3.10 Start-up scenario
• 3.11 Porter's analysis
• 3.12 PESTEL analysis
• 3.13 Future market trends
• 3.14 Gap analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 North America
  • 4.2.2 Europe
  • 4.2.3 Asia Pacific
  • 4.2.4 Latin America
  • 4.2.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn and Units)

• 5.1 Key trends
• 5.2 Videoendoscope
• 5.3 Fiberscope

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 GI endoscopy
• 6.3 Pulmonary endoscopy
• 6.4 ENT endoscopy
• 6.5 Urology
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and clinics
• 7.3 Ambulatory surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 BD
• 9.2 Boston Scientific
• 9.3 CooperSurgical
• 9.4 ENDOMED SYSTEMS
• 9.5 FUJIFILM
• 9.6 Laborie
• 9.7 Machida
• 9.8 OLYMPUS
• 9.9 PENTAX Medical
• 9.10 RICHARD WOLF
• 9.11 STORZ
• 9.12 XION